# David A. Scott

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-a-scott/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,862 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 39 |
| i10-index | 79 |
| Last Known Institution | Science Oxford |
| OpenAlex ID | https://openalex.org/A5039505685 |
| ORCID iD | 0000-0001-6475-8046 |
| Works | 194 |

## Researcher papers

- [Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2](https://scholariq.org/papers/conducting-indirect-treatment-comparison-and-network-meta-analysis-studies/)
- [Eliciting public preferences for healthcare: a systematic review of techniques](https://scholariq.org/papers/eliciting-public-preferences-for-healthcare-a-systematic-review-of-techniques/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications](https://scholariq.org/papers/a-systematic-review-and-consensus-definitions-for-standardised-end-points-in/)
- [Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial](https://scholariq.org/papers/network-meta-analysis-on-the-log-hazard-scale-combining-count-and-hazard-ratio/)
- [Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial](https://scholariq.org/papers/dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision-a/)
- [Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial](https://scholariq.org/papers/efficacy-and-safety-of-liraglutide-versus-placebo-as-add-on-to-glucose-lowering/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Screening for gestational diabetes: a systematic review and economic evaluation](https://scholariq.org/papers/screening-for-gestational-diabetes-a-systematic-review-and-economic-evaluation/)
- [Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods](https://scholariq.org/papers/valuing-health-care-using-willingness-to-pay-a-comparison-of-the-payment-card/)
- [The Economic Burden of Lupus Nephritis: A Systematic Literature Review](https://scholariq.org/papers/the-economic-burden-of-lupus-nephritis-a-systematic-literature-review/)
- [Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review](https://scholariq.org/papers/health-related-quality-of-life-fatigue-and-health-utilities-in-lupus-nephritis-a/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)

## Researcher university

- [Science Oxford](https://scholariq.org/institutions/science-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.